Literature DB >> 7566964

Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene.

D A Altomare1, K Guo, J Q Cheng, G Sonoda, K Walsh, J R Testa.   

Abstract

We isolated mouse cDNA clones containing the entire coding region of the putative oncogene Akt2. Sequence analysis revealed that, like its human homolog, Akt2 encodes a protein-serine/threonine kinase containing a pleckstrin homology domain at its amino terminus. Fluorescence in situ hybridization of the mouse cDNA to rodent metaphase spreads demonstrated that the Akt2 gene maps to mouse chromosome band 7B1 and rat chromosome 1q22. Expression levels of mouse Akt2 mRNA and Akt2 protein varied among tissues, with the highest levels in skeletal muscle. Akt2 expression was low in a multipotent fibroblast cell line, but it was upregulated when these cells were transformed with Myod and induced to differentiate into myocytes. These data demonstrate that Akt2 expression is activated during cellular differentiation and suggest that it functions in the signaling pathways of some adult tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566964

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

1.  Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival.

Authors:  Y Fujio; K Guo; T Mano; Y Mitsuuchi; J R Testa; K Walsh
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.

Authors:  Matthew P Stokes; Charles L Farnsworth; Albrecht Moritz; Jeffrey C Silva; Xiaoying Jia; Kimberly A Lee; Ailan Guo; Roberto D Polakiewicz; Michael J Comb
Journal:  Mol Cell Proteomics       Date:  2012-02-09       Impact factor: 5.911

3.  Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development.

Authors:  Fei Zhou; Zai Chang; Luqing Zhang; Young-Kwon Hong; Bin Shen; Bo Wang; Fan Zhang; Guangming Lu; Denis Tvorogov; Kari Alitalo; Brian A Hemmings; Zhongzhou Yang; Yulong He
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 4.  Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.

Authors:  Z Z Chong; F Li; K Maiese
Journal:  Histol Histopathol       Date:  2005-01       Impact factor: 2.303

Review 5.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

6.  Stem Cells in Aging: Influence of Ontogenic, Genetic and Environmental Factors.

Authors:  Edmond J Yunis; Joaquin Zúñiga; Prasad S Koka; Zaheed Husain; Viviana Romero; Joel N H Stern; Masha Fridkis-Hareli
Journal:  J Stem Cells       Date:  2006

7.  Role for the adaptor protein Grb10 in the activation of Akt.

Authors:  Thomas Jahn; Petra Seipel; Susanne Urschel; Christian Peschel; Justus Duyster
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

8.  Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells.

Authors:  H Sheng; J Shao; C M Townsend; B M Evers
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

9.  Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR.

Authors:  Chao-Yung Wang; Hyung-Hwan Kim; Yukio Hiroi; Naoki Sawada; Salvatore Salomone; Laura E Benjamin; Kenneth Walsh; Michael A Moskowitz; James K Liao
Journal:  Sci Signal       Date:  2009-03-17       Impact factor: 8.192

10.  Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta.

Authors:  Robert S Garofalo; Stephen J Orena; Kristina Rafidi; Anthony J Torchia; Jeffrey L Stock; Audrey L Hildebrandt; Timothy Coskran; Shawn C Black; Dominique J Brees; Joan R Wicks; John D McNeish; Kevin G Coleman
Journal:  J Clin Invest       Date:  2003-07-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.